1206801-37-7,
Merestinib dihydrochloride,
LY2801653 dihydrochloride,
UNII-33F79TLF60,
LY-2801653 dihydrochloride,
LY2801653 (dihydrochloride),
LY 2801653 dihydrochloride,
33F79TLF60,
BCP13049,
HY-15514A,
CS-1438,
Merestinib(LY2801653 dihydrochloride),
3-Pyridinecarboxamide, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-, hydrochloride (1:2),
QC-10484,
AB0098113,
W-6132,
LY-2801653 dihydrochloride;Merestinib dihydrochloride,
N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide;dihydrochloride,
A3574,
A15150,